Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Edwards Lifesciences Corp    EW

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Edwards Lifesciences Corp : Edwards Lifesciences to Host Earnings Conference Call on April 24, 2012

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/16/2012 | 10:28pm CET

IRVINE, CA, April 16, 2012

To participate in the conference call, dial (877) 407-8037 or (201) 689-8037. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using account number 2995 and conference number 392053. The call will also be available via live or archived webcast on the "Investor Relations" section of the Edwards web site at www.edwards.com or http://www.edwards.com/InvestorRelations/EventCalendar.htm.

About Edwards Lifesciences
Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives. Additional company information can be found at www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences and the stylized E logo are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office.

# # #
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EDWARDS LIFESCIENCES CORP
01/19 EDWARDS LIFESCIENCES : Trademark Application for "ASCENDRA" Filed by Edwards Lif..
01/19 EDWARDS LIFESCIENCES : An Application for the Trademark "PERIMOUNT THEON" Has Be..
01/19 EDWARDS LIFESCIENCES' : Trademark Application for "FLOTRAC" Filed
01/19 EDWARDS LIFESCIENCES : An Application for the Trademark "NOVAFLEX" Has Been File..
01/19 EDWARDS LIFESCIENCES : Trademark Application for "PACEPORT" Filed by Edwards Lif..
01/18 EDWARDS LIFESCIENCES : To Present At The 35th Annual J.P. Morgan Healthcare Conf..
01/17 EDWARDS LIFESCIENCES : To Host Earnings Conference Call On February 1, 2017
01/03 EDWARDS LIFESCIENCES : To Present At The 35th Annual J.P. Morgan Healthcare Conf..
2016 EDWARDS LIFESCIENCES : Trademark Application for "KONECT" Filed by Edwards Lifes..
2016 EDWARDS LIFESCIENCES : An Application for the Trademark "ADVANCED VENOUS ACCESS"..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
01/19 Davos CEOs 'go local' on supply chain in Trump era
01/08DJCorrection to Parkinson's Therapy Story
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
01/11 Dow Rally Is Running Out Of Steam - Cramer's Mad Money (1/10/17)
01/10 Edwards Lifesciences (EW) Investor Presentation - Slideshow
01/04 Political Ructions, Poor Deal-Making And Scandal - A Bad Year For Big-Cap Med..
01/04 Medtech News Over The Christmas Period
2016 Our Top 5 Insider Purchase Plays That Are Valid For 2017 And Beyond
Advertisement
Financials ($)
Sales 2016 2 955 M
EBIT 2016 817 M
Net income 2016 591 M
Finance 2016 709 M
Yield 2016 -
P/E ratio 2016 35,46
P/E ratio 2017 28,29
EV / Sales 2016 6,67x
EV / Sales 2017 5,99x
Capitalization 20 421 M
More Financials
Chart EDWARDS LIFESCIENCES CORP
Duration : Period :
Edwards Lifesciences Corp Technical Analysis Chart | EW | US28176E1082 | 4-Traders
Full-screen chart
Technical analysis trends EDWARDS LIFESCIEN...
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 116 $
Spread / Average Target 22%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Michael A. Mussallem Chairman & Chief Executive Officer
Scott B. Ullem Chief Financial Officer & Vice President
Stanton J. Rowe Chief Scientific Officer & VP-Advanced Technology
John T. Cardis Independent Director
Barbara J. McNeil Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EDWARDS LIFESCIENCES C..1.93%20 421
THERMO FISHER SCIENTIF..1.71%56 690
DANAHER CORPORATION3.46%55 703
BOSTON SCIENTIFIC CORP..10.49%32 544
PHILIPS-3.72%27 770
INTUITIVE SURGICAL, IN..3.56%25 447
More Results